Susquehanna International Group, LLP Axonics, Inc. Put Options Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	SELL	$67.3 - $69.67 $127,870 - $132,373	-1,900 Reduced 21.35%	7,000 $487,000
Q2 2024 Aug 15, 2024	SELL	$66.47 - $69.65 $2.65 Million - $2.78 Million	-39,900 Reduced 81.76%	8,900 $598,000
Q1 2024 May 07, 2024	BUY	$56.67 - $69.36 $1.79 Million - $2.18 Million	31,500 Added 182.08%	48,800 $3.37 Million
Q4 2023 Feb 14, 2024	SELL	$49.38 - $63.75 $814,770 - $1.05 Million	-16,500 Reduced 48.82%	17,300 $1.08 Million
Q3 2023 Nov 14, 2023	BUY	$48.64 - $62.51 $1.43 Million - $1.84 Million	29,500 Added 686.05%	33,800 $1.9 Million
Q2 2023 Aug 11, 2023	SELL	$47.99 - $60.21 $158,367 - $198,693	-3,300 Reduced 43.42%	4,300 $217,000
Q1 2023 May 16, 2023	BUY	$52.6 - $67.34 $220,920 - $282,828	4,200 Added 123.53%	7,600 $414,000
Q4 2022 Feb 14, 2023	SELL	$59.56 - $76.6 $226,328 - $291,080	-3,800 Reduced 52.78%	3,400 $212,000
Q3 2022 Nov 14, 2022	BUY	$57.96 - $78.12 $417,312 - $562,464	7,200 New	7,200 $507,000

234

42.1M

83.4K

65.3K

Ticker AXNX
Exchange NASDAQ
Sector Healthcare
Industry Medical Devices
Shares Outstandng 49,123,600
Market Cap $3.49B
Description
Axonics, Inc., a medical technology company, engages in the development and commercialization of sacral neuromodulation (SNM) systems. The company's SNM systems are used to treat patients with overactive bladder, including urinary urge incontinence and urinary urgency frequency, as well as fecal incontinence and non-obstructive urinary retention...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.